Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2023
1-1-2023 Teleallergy: Where Have We Been and Where Are We Going?, Allison Ramsey, Rochester Regional Health, Ann Chen Wu, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass., Bruce G. Bender, National Jewish Health, Denver, Colo., et al.
1-1-2023 Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product, S Shahzad Mustafa, Rochester Regional Health and Jodi Shroba, Allergy and Immunology, Children's Mercy Hospital, Kansas City, Missouri.
Submissions from 2022
12-1-2022 Bringing Data to Bear on the Mushy Middle: Riskier Immediate Reactions to Penicillin, Cosby A. Stone, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. and Allison Ramsey, Rochester Regional Health
12-1-2022 Effects of oral immunotherapy on immune tolerance, Peter Capucilli, Rochester Regional Health and David A. Hill, Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics and Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
12-1-2022 Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line, S Shahzad Mustafa, Rochester Regional Health; Nicholas L. Rider, Liberty University College of Osteopathic Medicine and the Liberty Mountain Medical Group, Lynchburg, Va.; and Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom.
12-1-2022 Primum Non Nocere, Marcus Shaker, Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Dartmouth Geisel School of Medicine, Hanover, NH. and Allison Ramsey, Rochester Regional Health
12-2022 Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies, Anthony J. Ocon, Rochester Regional Health, Kate E. Ocon, University of Rochester Medical Center, Rochester, NY, Jennifer Battaglia, University of Rochester Medical Center, Rochester, NY, et al.
11-1-2022 Air Pollution Effects in Allergies and Asthma, Anil Nanda, University of Texas Southwestern Medical Center, Dallas, TX, Syed Shahzad Mustafa, Rochester Regional Health, Maria Castillo, University of Texas Southwestern Medical Center, Dallas, TX, et al.
11-1-2022 Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee, Autumn C Guyer, Eric Macy, Andrew A White, et al.
11-1-2022 Evaluating Pediatric Penicillin Allergy-The Need to Broaden Indications and Improve Access, S Shahzad Mustafa, Rochester Regional Health and Allison C. Ramsey, Rochester Regional Health
10-11-2022 Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp, Stephanie A. Leonard, Division of Pediatric Allergy / Immunology, University of California San Diego, Rady Children's Hospital, San Diego, CA, United States., Yasushi Ogawa, Medical Affairs, Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States., Paul T. Jedrzejewski, Medical Affairs, Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States., et al.
9-2022 Peanut oral immunotherapy: Reconsidering a one-size-fits-all approach, Lakshmi G. Nair, Rochester Regional Health and Peter Capucilli, Rochester Regional Health
6-9-2022 Contact Dermatitis, Linh-An Tuong, Rochester Regional Health
6-9-2022 Penicillin Allergy and Perioperative Anaphylaxis, Allison Ramsey, Rochester Regional Health
6-2022 Should children with immunoglobulin E–mediated food allergy be screened for eosinophilic esophagitis?, Peter Capucilli, Rochester Regional Health, Allison Ramsey, Rochester Regional Health, Linh-An Tuong, Rochester Regional Health, et al.
5-23-2022 Patient and Clinician Attitudes Towards Telemedicine for Allergy and Immunology, Allison Ramsey, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Jay Portnoy, Section of Allergy, Asthma & Immunology. Children's Mercy Hospital, Kansas City, MO
5-9-2022 Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice, Jay Portnoy, Section of Allergy, Asthma & Immunology. Children's Mercy Hospital, Kansas City, MO, United States., Christina E. Ciaccio, Section of Allergy/Immunology and Pediatric Pulmonology, The University of Chicago, Chicago, IL, United States., Janet Beausoleil, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, United States., et al.
5-2022 Telemedicine in Drug Hypersensitivity, Deva Wells; Katherine L. DeNiro; and Allison Ramsey, Rochester Regional Health
5-1-2022 Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine, S. Shahzad Mustafa, Rochester Regional Health; Sara Patrawala; and Sandhya Khurana
4-12-2022 Practical Approach to Urticaria with Angioedema, Denise Sanchez Tejera, Rochester Regional Health
4-2022 Mise en place de l’immunothérapie orale pour l’allergie à l’arachide en pratique clinique aux États-Unis : huit conseils, S. Shahzad Mustafa, Rochester Regional Health and R Montagne, Aimmune Therapeutics
4-1-2022 Real World Adoption of FDA-approved Peanut Oral Immunotherapy with Palforzia, Sara Patrawala, University of Rochester School of Medicine and Dentistry, Rochester NY., Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.
4-2022 Standardisation de la poudre de graine d’Arachis hypogaea L. (arachide) allégée en graisses (PDAH) pour une immunothérapie orale : test des lots de matériel source, S A. Leonard, University of California San Diego; R Montagne, Aimmune Therapeutics; and S. Shahzad Mustafa, Rochester Regional Health
3-2022 Anaphylaxis knowledge gaps and future research priorities: A consensus report, Timothy E. Dribin, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., David Schnadower, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Julie Wang, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY., et al.
2-1-2022 Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of β-Lactam Cross-Reactivity, Allison Ramsey, Rochester Regional Health